Improving early detection of liver cancer through collaboration and data management.
Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)
This study is working to find better ways to spot liver cancer early by bringing together scientists from different fields to identify helpful markers for patients with cirrhosis, which could lead to quicker diagnoses and better treatment options for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10927360 on NIH RePORTER |
What this research studies
This research focuses on enhancing the early detection of liver cancer by fostering collaboration among scientists from various disciplines. It aims to evaluate and prioritize promising biomarkers that can improve surveillance and risk stratification for patients with cirrhosis. The project involves creating and maintaining integrated databases and biorepositories to support collaborative studies and ensure effective communication among researchers. Patients may benefit from improved detection methods that could lead to earlier diagnosis and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cirrhosis who are at risk for developing liver cancer.
Not a fit: Patients without liver disease or those who do not have cirrhosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of liver cancer, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown success in using collaborative approaches and biomarker evaluation for cancer detection, indicating a promising avenue for this project.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Feng, Ziding — Fred Hutchinson Cancer Center
- Study coordinator: Feng, Ziding
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.